Covid19 Primer

Title	Date	Topic	News	Relevance
Effectiveness of tailored COVID-19 messages for vulnerable Australians: A study protocol Megan Jepson et al in plos one (3.24) Source crossref_works_2020_03_25	Jan 27, 2023	Placebo-controlled & Randomized	0	0.2
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open label interventional study Avner Ehrlich et al in elife (8.14) Source crossref_works_2020_03_25	Jan 27, 2023	Placebo-controlled & Randomized	0	0.3
The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium Enya Daynes et al in trials (2.279) Source crossref_works_2020_03_25	Jan 26, 2023	Placebo-controlled & Randomized	0	0.2
Photodynamic nasal SARS-CoV-2 decolonization shortens infectivity and influences specific T-Cell responses Alejandro Fernandez-Montero et al in frontiers in cellular and infection microbiology (5.293) Source crossref_works_2020_03_25	Jan 25, 2023	Placebo-controlled & Randomized	1	0.5
Safety, Tolerability and Pharmacokinetics of Half-Life Extended SARS-CoV-2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab/Cilgavimab) in Healthy Adults Pablo Forte-Soto et al in journal of infectious diseases (5.226) Source crossref_works_2020_03_25	Jan 23, 2023	Placebo-controlled & Randomized	0	0.5
Phase 2 safety and antiviral activity of SAB-185, a novel polyclonal antibody therapy for non-hospitalized adults with COVID-19 Babafemi O Taiwo et al in journal of infectious diseases (5.226) Source crossref_works_2020_03_25	Jan 20, 2023	Placebo-controlled & Randomized	0	0.3
Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial Ahmed Kamal et al in bmc infectious diseases (3.09) Source crossref_works_2020_03_25	Jan 20, 2023	Placebo-controlled & Randomized	0	0.3
Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial Jiande Chen et al in frontiers in pharmacology (5.81) Source crossref_works_2020_03_25	Jan 19, 2023	Placebo-controlled & Randomized	0	0.5
The possible therapeutic role of curcumin and quercetin in the early-stage of COVID-19—Results from a pragmatic randomized clinical trial Ikram Din Ujjan et al in frontiers in nutrition (6.576) Source crossref_works_2020_03_25	Jan 18, 2023	Placebo-controlled & Randomized	1	0.3
Ongoing Treatment with a Spore-Based Probiotic Containing Five Strains of Bacillus Improves Outcomes of Mild COVID-19 Adrian Catinean et al in nutrients (5.717) Source crossref_works_2020_03_25	Jan 17, 2023	Placebo-controlled & Randomized	0	0.3